Please login to the form below

Not currently logged in


This page shows the latest Mavenclad news and features for those working in and with pharma, biotech and healthcare.

MS and cholesterol drugs picked for new UK rapid uptake push

MS and cholesterol drugs picked for new UK rapid uptake push

Rival cholesterol lowering drugs Sanofi's Praluent and Amgen’s Repatha and Merck’s multiple sclerosis treatment Mavenclad have been selected as high priority products for rapid uptake in England. ... It was nearly a year ago that NHS England struck a

Latest news

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Pharma: in search of the sustainable ‘win win’ with the NHS Pharma: in search of the sustainable ‘win win’ with the NHS

    The company has just secured 'Rapid Uptake' status for its multiple sclerosis drug Mavenclad via the new Accelerated Access Collaborative process.

  • Tackling a formidable foe Tackling a formidable foe

    MAVENCLAD offers lasting control of the disease allowing them to plan for pregnancy once the treatment course is completed. ... MAVENCLAD’S short-course oral therapy profile is a bonus to a condition freighted with psychological drag-weights.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...